Vermeulen, K.; Van de Voorde, M.; Segers, C.; Coolkens, A.; Rodriguez Pérez, S.; Daems, N.; Duchemin, C.; Crabbé, M.; Opsomer, T.; Saldarriaga Vargas, C.;
et al. Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [153Sm]Sm-DOTA-TATE. Pharmaceutics 2022, 14, 2566.
https://doi.org/10.3390/pharmaceutics14122566
AMA Style
Vermeulen K, Van de Voorde M, Segers C, Coolkens A, Rodriguez Pérez S, Daems N, Duchemin C, Crabbé M, Opsomer T, Saldarriaga Vargas C,
et al. Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [153Sm]Sm-DOTA-TATE. Pharmaceutics. 2022; 14(12):2566.
https://doi.org/10.3390/pharmaceutics14122566
Chicago/Turabian Style
Vermeulen, Koen, Michiel Van de Voorde, Charlotte Segers, Amelie Coolkens, Sunay Rodriguez Pérez, Noami Daems, Charlotte Duchemin, Melissa Crabbé, Tomas Opsomer, Clarita Saldarriaga Vargas,
and et al. 2022. "Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [153Sm]Sm-DOTA-TATE" Pharmaceutics 14, no. 12: 2566.
https://doi.org/10.3390/pharmaceutics14122566
APA Style
Vermeulen, K., Van de Voorde, M., Segers, C., Coolkens, A., Rodriguez Pérez, S., Daems, N., Duchemin, C., Crabbé, M., Opsomer, T., Saldarriaga Vargas, C., Heinke, R., Lambert, L., Bernerd, C., Burgoyne, A. R., Cocolios, T. E., Stora, T., & Ooms, M.
(2022). Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [153Sm]Sm-DOTA-TATE. Pharmaceutics, 14(12), 2566.
https://doi.org/10.3390/pharmaceutics14122566
